Meta-Analysis
Copyright ©The Author(s) 2023.
World J Gastrointest Endosc. Mar 16, 2023; 15(3): 177-190
Published online Mar 16, 2023. doi: 10.4253/wjge.v15.i3.177
Table 5 Demographics, procedural, and survival outcomes of endoscopic radiofrequency ablation vs photodynamic therapy

Demographic data
Strand et al[13], 2014
Schmidt et al[15], 2016
Gao et al[14], 2018
Number of patientsRFA16P = 0.1RFA14NARFA
PDT32PDT20PDT
Gender (male)RFA10P = 1.0RFA8P = 0.1RFA
PDT19PDT6PDT
Age (mean, yr)RFA64.3 ± 11.9P = 0.1RFA73 ± 9P = 0.2RFA
PDT69.5 ± 13.6PDT70 ± 12PDT
Number of treatmentsRFA28 (mean: 1.2)P = 0.02RFA31NARFA
PDT60 (mean: 2.1)PDT36PDT
Median survival (month)RFA9.6P = 0.8RFANANARFA
PDT7.5PDTNAPDT
Lead time to initial treatment (days)RFANSP = 0.6RFA300 ± 270NARFA
PDTNSPDT120 ± 90PDT
Total bilirubin concentration (µmol/dL)RFANANARFA3.3 ± 3.9P = 0.7RFA
PDTNAPDT4.1 ± 6.9PDT
Tumor locationRFAIntrahepatic1P = 0.1RFAIntrahepatic1P = 0.5RFA
Hilar13Hilar11
Distal/Extrahepatic2Distal/Extrahepatic1
PDTIntrahepatic0PDTIntrahepatic3PDT
Hilar32Hilar15
Distal/Extrahepatic0Distal/Extrahepatic1
N1 stagingRFA7P = 0.8RFA3P = 0.4RFA
PDT12PDT2PDT
M1 stagingRFA6P = 0.2RFA2P = 0.8RFA
PDT6PDT6PDT
Stents placedTotalRFA115NATotalRFA29NATotal
PDT307PDT44
PlasticRFA69NAPlasticRFA26NAPlastic
PDT264PDT38
Total metallicRFA46NATotal metallicRFA3NATotal metallic
PDT43PDT6
Fully coveredRFA17NAFully coveredRFANANAFully covered
PDT14PDTNA
UncoveredRFA29NAUncoveredRFANANAUncovered
PDT29PDTNA
Number of ERCPsRFA91NARFANANARFA
PDT170PDTNAPDT
Percutaneous transhepatic biliary drainage (PTBD)RFA2P = 0.2RFA2P = 0.3RFA
PDT10PDT6PDT